HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02

Clinical trial NCT02525302 · TERMINATED

Trial details

NCT number: NCT02525302
Sponsor: Akashi Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2015-05-01
Primary completion: 2016-12-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.